Concepedia

Can Xu

CX

4

Publications

129

Citations

4

H-Index

2019

Active since

Affiliations

University of South China(Current)

First Affiliated Hospital of University of South China

Can Xu is an author at University of South China specializing in cell biology, cell signaling, and inflammation.

Top concepts

Publications per year

2019–2022

4

Publications

4

Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway

Jin Zou, Can Xu, Zhen-Wang Zhao et al. · Journal of Translational Medicine · 2022 · 57 citations · Full text

MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1

Can Xu, Changhui Liu, Dali Zhang · Biochemical and Biophysical Research Communications · 2019 · 32 citations

, , +4

MicroRNA‐495‐3p diminishes doxorubicin‐induced cardiotoxicity through activating AKT

Jun Meng, Can Xu · Journal of Cellular and Molecular Medicine · 2022 · 23 citations · Full text

LncRNA KCNQ1OT1 knockdown inhibits ox-LDL-induced inflammatory response and oxidative stress in THP-1 macrophages through the miR-137/TNFAIP1 axis

Can Xu, Lei Chen, Rujing Wang et al. · Cytokine · 2022 · 17 citations

, , +8

Rows per page

1–4 of 4